Qube Research & Technologies Ltd - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,202
-99.5%
6,021
-98.8%
0.00%
-100.0%
Q4 2022$1,256,890
+187.6%
502,756
+385.4%
0.01%
+133.3%
Q3 2022$437,000
+97.7%
103,585
+30.6%
0.00%
+50.0%
Q2 2022$221,000
-49.9%
79,297
+2.9%
0.00%
-50.0%
Q1 2022$441,000
+224.3%
77,081
+567.8%
0.00%
-33.3%
Q1 2020$136,000
-66.4%
11,543
-33.0%
0.01%
-53.8%
Q4 2019$405,00017,2300.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders